• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Hirano Tsutomu  平野 勉

ORCIDConnect your ORCID iD *help
… Alternative Names

HIRANO Tsutomu  平野 勉

Less
Researcher Number 00167610
Affiliation (Current) 2025: 昭和大学, 医学部, 名誉教授
Affiliation (based on the past Project Information) *help 2012: 昭和大学, 医学部, 教授
2010: 昭和大学, 医学部, 教授
2006 – 2008: 昭和大学, 医学部, 教授
2002 – 2003: 昭和大学, 医学部, 助教授
2000: 昭和大, 医学部, 助教授
1999 – 2000: 昭和大学, 医学部, 助教授
Review Section/Research Field
Principal Investigator
Metabolomics
Except Principal Investigator
Circulatory organs internal medicine / Metabolomics
Keywords
Principal Investigator
Insulin resistance / LPL deficiency / pre heparin plasma / lipoprotein lipase / トリグリセライド / LPL欠損症 / インスリン抵抗性 / リポ蛋白リパーゼ / Diabetes / Hypertriglyceridemia … More / Apo CIII / Apo CI / マウス / 糖尿病性腎症 / アポE / レムナント / アポC3 / アポCl / 糖尿病 / 高トリグリセライド血症 / アポCIII / アポCI … More
Except Principal Investigator
マクロファージ / 動脈硬化 / サリューシン / 高血圧 / 血管作動性物質 / Macrophage Foam Cell Formation / Salusin / Urotensin ll / Complications / Atherosclerosis / Hypertension / Vasoactive Agents / 高血圧合併症 / マクロファージ泡沫化 / ウロテンシンII / 合併症 / ACAT-1 / CD36 / 泡沫化 / マクロファージの泡沫化 / 糖尿病 / DPP-4阻害剤 / インクレチン / 分子血管病態学 / 酵素 / コレステロール / 蛋白質 / 接着分子 / 内皮細胞 / 単球 Less
  • Research Projects

    (5 results)
  • Research Products

    (35 results)
  • Co-Researchers

    (6 People)
  •  Therapeutic Strategy of Diabetic Macroangiopathy using the Gut Hormone Incretin

    • Principal Investigator
      WATANABE Takuya
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Circulatory organs internal medicine
    • Research Institution
      Tokyo University of Pharmacy and Life Science
  •  Regulation of macrophage foam cell formation and atherosclerosis by novel regulatory peptides for cardiovascular system

    • Principal Investigator
      MIYAZAKI Akira
    • Project Period (FY)
      2008 – 2010
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Metabolomics
    • Research Institution
      Showa University
  •  Mechanisms of Macrophage Foam Cell Formation and Hypertensive Complications Caused by Vasoactive Agents

    • Principal Investigator
      WATANABE Takuya
    • Project Period (FY)
      2006 – 2007
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Circulatory organs internal medicine
    • Research Institution
      Showa University
  •  Clinical significance of preheparin lipoprotein lipase massPrincipal Investigator

    • Principal Investigator
      HIRANO Tsutomu
    • Project Period (FY)
      2002 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Metabolomics
    • Research Institution
      Showa University
  •  Physiological and clinical significance of apolipoprotein CIPrincipal Investigator

    • Principal Investigator
      HIRANO Tsutomu
    • Project Period (FY)
      1999 – 2000
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Metabolomics
    • Research Institution
      SHOWA UNIVERSITY

All 2011 2010 2009 2008 2007 2006

All Journal Article Presentation

  • [Journal Article] Chronic infusion of salusin-α and-β exerts opposite effects on macrophage foam cell formation and atherosclerosis in apolipoprotein E-deficient mice.2010

    • Author(s)
      Nagashima M, Watanabe T, Hirano T, et al.
    • Journal Title

      Atherosclerosis

      Volume: 212 Pages: 70-77

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Journal Article] Chronic infusin of salusin-α and salusin-β exerts opposite effects on atherosclerostic lesion development in apolipoprotein E-deficient mice.2010

    • Author(s)
      Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T
    • Journal Title

      Atherosclerosis 212(1)

      Pages: 70-77

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591084
  • [Journal Article] Ezetimibe decreases serum amyloid A levels in HDL3 in hemodialysis patients.2010

    • Author(s)
      Hirano T, Watanabe T, et al.
    • Journal Title

      Clinical Nephrology

      Volume: 74 Pages: 282-287

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Journal Article] インクレチン関連薬の糖代謝以外の作用効果2010

    • Author(s)
      長嶋理晴、渡部琢也、平野勉
    • Journal Title

      診断と治療

      Volume: 98 Pages: 415-421

    • Data Source
      KAKENHI-PROJECT-22590831
  • [Journal Article] 糖尿病治療を変える新たな糖尿病薬インクレチン2010

    • Author(s)
      李相翔、長嶋理晴、平野勉、渡部琢也
    • Journal Title

      昭和医学会雑誌

      Volume: 70 Pages: 34-44

    • NAID

      130000852880

    • Data Source
      KAKENHI-PROJECT-22590831
  • [Journal Article] Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia.2009

    • Author(s)
      Ban Y, Watanabe T, Suguro T, Matsuyama T, Iso Y, Sakai T, Sato R, Idei T, Nakano Y, Ota H, Miyazaki A, Kato N, Hirano T, Ban Y, Kobayashi Y
    • Journal Title

      Journal of Atherosclerosis and Thrombosis 16(3)

      Pages: 179-187

    • NAID

      10025765398

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591084
  • [Journal Article] Preventive effects of heregulin-β1 on macrophage foam cell formation and atherosclerosis.2009

    • Author(s)
      Xu G, Watanabe T, Iso Y, Koba S, Sakai T, Nagashima M, Arita S, Hongo S, Ota H, Kobayashi Y, Miyazaki A, Hirano T
    • Journal Title

      Circulation Research 105(5)

      Pages: 500-510

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591084
  • [Journal Article] Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in type 2 diabetes mellitus.2008

    • Author(s)
      Suguro T, Watanabe T, Kodate S, Xu G, Hirano T, Adachi M, Miyazaki A
    • Journal Title

      Clinical Science 115(11)

      Pages: 327-334

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591084
  • [Journal Article] Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.2008

    • Author(s)
      Shiraishi Y, Watanabe T, Suguro T, Kato R, Hongo S, Itabe H, Miyazaki A, Hirano T, Adachi M
    • Journal Title

      Journal of Hypertension 26(10)

      Pages: 1955-1965

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591084
  • [Journal Article] Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension2007

    • Author(s)
      Suguro, T., Watanabe, T., Hirano, T., Miyazaki, A., et. al.
    • Journal Title

      Am J Hypertens 20

      Pages: 211-217

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-18590824
  • [Journal Article] Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension2007

    • Author(s)
      Suguro T, Watanabe T, Hirano T, Miyazaki A, et. al.
    • Journal Title

      Am J Hypertens 20

      Pages: 211-217

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18590824
  • [Journal Article] Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats : an implication for hypertension-related insulin resistance.2006

    • Author(s)
      Ran J, Hirano T, et al.
    • Journal Title

      Metabolism 55

      Pages: 478-478

    • Data Source
      KAKENHI-PROJECT-18590824
  • [Journal Article] Opposing actions of angiotensin II type 1 and 2 receptors on plasma cholesterol levels in rats.2006

    • Author(s)
      Hirano T, et al.
    • Journal Title

      J Hypertyens 24

      Pages: 103-108

    • Data Source
      KAKENHI-PROJECT-18590824
  • [Presentation] Native incretins suppress the proliferation and migration of vascular smooth muscle cells2011

    • Author(s)
      Tomoyasu M, Nagashima M, Watanabe T,Hirano T, et al
    • Organizer
      3rd Scientific Meeting of the Asian Association for the Study of Diabetes
    • Place of Presentation
      Beijing, China
    • Year and Date
      2011-07-23
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Glucose-dependent insulinotropic polypeptide suppresses the development of atherosclerosis in apolipoprotein E-null mice via its own receptors2011

    • Author(s)
      Terasaki M, Nagashima M, Watanabe T,Hirano T, et al
    • Organizer
      第43回日本動脈硬化学会学術集会
    • Place of Presentation
      札幌
    • Year and Date
      2011-07-15
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] DPP-4阻害剤はアポEノックアウトマウスの動脈硬化進展を抑制する2011

    • Author(s)
      寺崎道重、長嶋理晴、平野勉、渡部琢也
    • Organizer
      第58回昭和医学会総会
    • Place of Presentation
      東京
    • Year and Date
      2011-11-26
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] GIPの慢性持続投与はApoE 欠損マウスの動脈硬化進展を抑制する2011

    • Author(s)
      長嶋理晴、渡部琢也、平野勉
    • Organizer
      第54回日本糖尿病学会年次学術集会
    • Place of Presentation
      札幌
    • Year and Date
      2011-05-20
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Preventive effects of heregulin-β1 on macrophage foam cell formation and atherosclerosis.2010

    • Author(s)
      渡部琢也・有田茂子・長嶋理晴・平野勉・宮崎章・他
    • Organizer
      第42回日本動脈硬化学会学術集会
    • Place of Presentation
      岐阜
    • Data Source
      KAKENHI-PROJECT-20591084
  • [Presentation] Incretin-based treatments prevent the development of atherosclerotic lesions in apolipoprotein E-null mice2010

    • Author(s)
      Watanabe T, Nagashima M, Hirano T, et al
    • Organizer
      83rd Scientific Sessions of the American Heart Association
    • Place of Presentation
      Chicago, Illinois, USA
    • Year and Date
      2010-10-17
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Incretins prevent the development of atherosclerosis in apolipoprotein E-null mice.2010

    • Author(s)
      長嶋理晴、寺崎道重、渡部琢也、平野勉
    • Organizer
      第42回日本動脈硬化学会学術集会
    • Place of Presentation
      岐阜
    • Year and Date
      2010-07-16
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Incretins prevent the development of atherosclerosis in apolipoprotein E-null mice2010

    • Author(s)
      長嶋理晴、渡部琢也、平野勉
    • Organizer
      第42回 日本動脈硬化学会学術集会
    • Place of Presentation
      岐阜
    • Year and Date
      2010-07-16
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Incretins directly suppress the development papolipoprotein E-null mice of macrophage-driven atherosclerosis in apolipoprotein E-null mice2010

    • Author(s)
      Hirano T, Nagashima M, Watanabe T, et al.
    • Organizer
      46th Annual Meeting of the European Association for the Study of Diabetes
    • Place of Presentation
      Stockholm, Sweden
    • Year and Date
      2010-09-22
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Incretins directly suppress the development of macrophage-driven atherosclerosis in apolipoprotein E-null mice2010

    • Author(s)
      Hirano T, Nagashima M, Watanabe T, et al
    • Organizer
      46th Annual Meeting of the European Association for the Study of Diabetes
    • Place of Presentation
      Stockholm, Sweden
    • Year and Date
      2010-09-22
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Incretins prevent the development of atherosclerosis in apolipoprotein E-null mice2010

    • Author(s)
      Nagashima M, Watanabe T, Hirano T, et al
    • Organizer
      70th Scientific Sessions of the American Diabetes Association
    • Place of Presentation
      Orland, Florida, USA
    • Year and Date
      2010-06-29
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Incretin-based treatments prevent the development of atherosclerotic lesions in apolipoprotein E-null mice.2010

    • Author(s)
      Watanabe T, Nagashima M, Hirano T, et al.
    • Organizer
      83rd Scientific Sessions of the American Heart Association
    • Place of Presentation
      Chicago, Illinois, USA
    • Year and Date
      2010-11-17
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Incretins prevent the development of atherosclerosis in apolipoprotein E-null mice2010

    • Author(s)
      Nagashima M, Watanabe T, Hirano T, et al
    • Organizer
      Asia Lslet Biology & Incretin Symposium
    • Place of Presentation
      Kyoto, Japan
    • Year and Date
      2010-07-31
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] ApoE欠損マウスにおけるGLP-1の持続投与が動脈硬化に及ぼす影響2010

    • Author(s)
      長嶋理晴、渡部琢也、平野勉
    • Organizer
      第53回日本糖尿病学会年次学術集会
    • Place of Presentation
      岡山
    • Year and Date
      2010-05-28
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Incretins prevent the development of atherosclerosis in apolipoprotein E-null mice.2010

    • Author(s)
      Nagashima M, Watanabe T, Hirano T, et al.
    • Organizer
      70th Scientific Sessions of the American Diabetes Association
    • Place of Presentation
      Orland, Florida, USA
    • Year and Date
      2010-06-29
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Incretins prevent the development of atherosclerosis in apolipoprotein E-null mice.2010

    • Author(s)
      Nagashima M, Watanabe T, Hirano T, et al.
    • Organizer
      Asia Lslet Biology & Incretin Symposium
    • Place of Presentation
      Kyoto, Japan
    • Year and Date
      2010-07-31
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Preventive effects of heregulin-β1, a nerve growth factor, on macrophage foam cell formation and atherosclerosis2010

    • Author(s)
      渡部琢也、平野勉, 他
    • Organizer
      第42回日本動脈硬化学会学術集会
    • Place of Presentation
      岐阜
    • Year and Date
      2010-07-15
    • Data Source
      KAKENHI-PROJECT-22590831
  • [Presentation] Chronic infusion of salusin-α and -β exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-knockout mice.2009

    • Author(s)
      長嶋理晴・渡部琢也・宮崎 章・平野勉
    • Organizer
      第41回日本動脈硬化学会学術集会
    • Place of Presentation
      下関
    • Data Source
      KAKENHI-PROJECT-20591084
  • [Presentation] Opposite effects of salusins on the development of atherosclerotic plaques.2009

    • Author(s)
      Watanabe T, Nagashima M, Arita S, Hongo S, Shichiri M, Hirano T, Miyazaki A
    • Organizer
      American Heart Association Scientific Sessions 2009
    • Place of Presentation
      Orlando
    • Data Source
      KAKENHI-PROJECT-20591084
  • [Presentation] 血漿ウロテンシンII(UII)濃度の増加と糖尿病性網膜症との関連2008

    • Author(s)
      勝呂俊昭・渡部琢也・宮崎 章・平野勉・他
    • Organizer
      第51回日本糖尿病学会年次学術集会
    • Place of Presentation
      東京
    • Data Source
      KAKENHI-PROJECT-20591084
  • [Presentation] 血漿ウロテンシンII(UII)濃度の増加と糖尿病性網膜症および頸動脈硬化との関連2008

    • Author(s)
      勝呂俊昭・渡部琢也・宮崎章・平野勉, 他
    • Organizer
      第40回日本動脈硬化学会学術集会
    • Place of Presentation
      つくば
    • Data Source
      KAKENHI-PROJECT-20591084
  • [Presentation] Increased human urotensin II levels are correlated with carotid atherosclerosis in 〓2006

    • Author(s)
      Suguro, T., Watanabe, T., Hirano, T., Miyazaki, A., et. al.
    • Organizer
      American Heart Association Scientific Sessions 2006
    • Place of Presentation
      Chicago, Illinois, USA
    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-18590824
  • 1.  WATANABE Takuya (30297014)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 33 results
  • 2.  MIYAZAKI Akira (70253721)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 13 results
  • 3.  SHICHIRI Masayoshi (10206097)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 4.  KOBA Shinji (20276546)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  NAGASHIMA Masaharu (20468606)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 18 results
  • 6.  鹿目 知子 (70420908)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi